Evidence map›Paper›PMID 38136075›Full record

ArticleChildren (Basel, Switzerland)2023

Parents' Perceptions Regarding Their Children's Medications and Expert-Assessed Drug-Related Problems in Pediatric Patients with Inborn Errors of Metabolism.

Tanjana Harings, Martina Patrizia Neininger, Simone Eisenhofer, Alena Gerlinde Thiele, Wieland Kiess, Astrid Bertsche, Skadi Beblo, Thilo Bertsche

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Medication Barriers and Challenges Experienced/Perceived by Caregivers in Pediatric Medication Management: A Scoping Review.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tanjana HaringsInstitute of Pharmacy, Clinical Pharmacy, Medical Faculty, Leipzig University, Bruederstrasse 32, 04103 Leipzig, Germany.ORCID 0009-0002-2721-1775
Martina Patrizia NeiningerInstitute of Pharmacy, Clinical Pharmacy, Medical Faculty, Leipzig University, Bruederstrasse 32, 04103 Leipzig, Germany.ORCID 0000-0002-5208-0888
Simone EisenhoferInstitute of Pharmacy, Clinical Pharmacy, Medical Faculty, Leipzig University, Bruederstrasse 32, 04103 Leipzig, Germany.ORCID 0000-0001-7206-7384
Alena Gerlinde ThieleCenter for Pediatric Research, University Hospital for Children and Adolescents, Liebigstrasse 20a, 04103 Leipzig, Germany.ORCID 0000-0003-2880-1355
Wieland KiessCenter for Pediatric Research, University Hospital for Children and Adolescents, Liebigstrasse 20a, 04103 Leipzig, Germany.ORCID 0000-0003-4118-9455
Astrid BertscheCenter for Pediatric Research, University Hospital for Children and Adolescents, Liebigstrasse 20a, 04103 Leipzig, Germany.ORCID 0000-0003-2832-0156
Skadi BebloCenter for Pediatric Research, University Hospital for Children and Adolescents, Liebigstrasse 20a, 04103 Leipzig, Germany.ORCID 0000-0002-7376-6512
Thilo BertscheInstitute of Pharmacy, Clinical Pharmacy, Medical Faculty, Leipzig University, Bruederstrasse 32, 04103 Leipzig, Germany.ORCID 0000-0002-4930-6655
University Hospital Leipzig · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to explore parents' perceptions of their children's medication use for inborn errors of metabolism (IEM), including the importance of medication intake, potential complications, and concerns about adverse drug reactions (ADR). Additionally, we aimed to determine expert-assessed clinically relevant drug-related problems, particularly those attributable to IEM. We interviewed 108 parents of 119 pediatric patients with IEM using a questionnaire relating to their perceptions regarding their children's IEM medication. In affected siblings, a questionnaire was used for each child. We performed medication analyses to evaluate the patient's complete medication regimen for clinically relevant drug-related problems, including medication for conditions other than IEM. It was very important to the parents of 85% of the patients to use IEM medication exactly as prescribed. The parents of 41% of patients perceived complications in their children's use of IEM medication. The parents of 47% of patients reported fears concerning ADR because of IEM medication. Parents observed ADR in 27% of patients because of IEM medication. In 44% of patients, medication for conditions other than IEM was inadequate because of drug-related problems not associated with the IEM; a safe alternative existed in 21% of patients. In summary, almost half of the parents of patients with IEM reported complications with their child's IEM medication intake and fears of ADR. Medication analyses showed that drug-related problems occurred regardless of IEM, emphasizing the general need to prescribe and dispense adequate, child-appropriate medication to minimize clinically relevant drug-related problems in pediatric patients.

Indexed as

adverse drug reactiondrug-related problemsinborn errors of metabolisminherited metabolic diseasemedicationparentspediatricperceptions

Identifiers

PMID38136075
PMCPMC10741610
OpenAlexW4389134319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.